Results

Total Results: 1,991 records

Showing results for "participant".

81. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - RCTs often have narrow participant eligibility criteria that exclude some subsets of the population, … longitudinal Retrospective • May be useful for rare diseases or newer interventions • Ease of participant … They lack participant follow-up and therefore do not allow inference regarding temporality of the association … The closer to 1, the stronger the probability that the participant would be in the intervention group … ; likewise, the closer to 0, the stronger the probability the participant would be in the control group

82. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - RCTs often have narrow participant eligibility criteria that exclude some subsets of the population, … longitudinal Retrospective • May be useful for rare diseases or newer interventions • Ease of participant … They lack participant follow-up and therefore do not allow inference regarding temporality of the association … The closer to 1, the stronger the probability that the participant would be in the intervention group … ; likewise, the closer to 0, the stronger the probability the participant would be in the control group

83. The Evidence-Based Care Challenge: A Case Study (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-case-130621.pdf
    June 01, 2013 - This process facilitated participant-to-participant communication, and was maintained until the close

84. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-standardized-library_0.pdf
    February 01, 2019 - Began discussing key participant, provider, and disease characteristics that should be collected … Continued discussion of participant, provider, and disease characteristics. … Defining Participant, Provider, and Disease Characteristics The first OMF domain describes characteristics … of the participant, disease, and provider that are important for fully defining an outcome measure … For each of the five clinical areas, the project team developed an initial list of participant, disease

85. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
    February 01, 2019 - Began discussing key participant, provider, and disease characteristics that should be collected … Continued discussion of participant, provider, and disease characteristics. … Defining Participant, Provider, and Disease Characteristics The first OMF domain describes characteristics … of the participant, disease, and provider that are important for fully defining an outcome measure … For each of the five clinical areas, the project team developed an initial list of participant, disease

86. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - Imunodiagnostic Products; developed at Centers for Disease Control Only one sample for serology per participant … who tested positive for SARS-CoV-2 infection at South West London Pathology during the study period Participant … cohort May-September 2020 to January 25, 2021 ~6.75 months (27 weeks) NR HCW & other essential workers Participant … Switzerland Data of SARS-CoV-2 infections was extracted from a centralized state registry and linked to each participant

87. Fiber Intake and Laxation Outcomes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol.pdf
    August 15, 2023 - allocation concealment, and outcome assessor blinding are all unclear (with the recognition that the participant … Each study will be described in summary and evidence tables presenting study design features, study participant

88. Rti-Item-Bank Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rti-item-bank_research.pdf
    August 01, 2013 - than zero) of being assigned to each of the evaluated interventions. 3 Randomization offers a participant … all study participants used to assess inclusion/exclusion criteria, intervention/exposure outcomes, participant … all study participants used to assess inclusion/exclusion criteria, intervention/exposure outcomes, participant … across all study participants to assess inclusion/exclusion criteria, intervention/exposure outcomes, participant … study participants used to assess inclusion/exclusion criteria, intervention/exposure outcomes, participant

89. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2024 Update of the Evidence Base for the PTSD Trials Standardized Data Repository (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-draft-report.pdf
    February 05, 2024 - Summary of all included studies: studies by participant sex ....................................... 19 … About half of studies allowed a mix of trauma types (53%); 38 percent did not provide information on participant … PTSD diagnosis or symptoms, number of treatment-naïve participants, mean number of trauma types per participant … Summary of all included studies: studies by participant sex 3.2.1 Results, Characteristics of … data, subgroup analyses (e.g., to provide data on what works for whom), participant populations with

90. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
    September 12, 2019 - and exclusion criteria, intervention and control characteristics, sample size, follow-up duration, participant … bias of eligible RCTs will be assessed using the Cochrane Risk of Bias Tool. 14 Components include participant

91. Appendix-Table-B-1-Observational-Studies (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
    March 20, 2021 - Serology done using "locally validated assays" NR Possible reinfection defined as a positive cohort participant … with two PCR+ samples ≥90 days apart, or a positive cohort participant with a new PCR+ test at least

92. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
    December 21, 2010 - Population characteristics: inclusion/exclusion criteria, numbers enrolled and analyzed, participant … Observational controlled studies Uncontrolled experimental (for KQ 5 only) a Appropriateness of participant … Selection Bias Appropriateness of participant selection a X X X Randomization sequence generation … Methodological diversity will be explored by adequacy of participant selection, important confounding

93. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - : inclusion/exclusion criteria, numbers enrolled and analyzed, participant characteristics (age, … controlled studies Uncontrolled experimental (for KQ 5 only) Selection Bias Appropriateness of participant … mode of harms collection (e.g., active or passive, standard tool) X X X aAppropriateness of participant … Methodological diversity will be explored by adequacy of participant selection, important confounding

94. Innovations in Stakeholder Engagement Conference Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/innovations_in_stakeholder_engagement_conference_summary2.pdf
    October 01, 2011 - • Nurture the community by dedicating staff to assist in promoting participant interaction and summarizing

95. Slide 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_educatingsessionparticipants.pdf
    May 18, 2012 - Slide 1 Educating Session Participants Susan Dorr Goold, MD, MHSA, MA Professor of Internal Medicine and Health Management and Policy University of Michigan 1 Educating Session Participants • Deliberative procedures usually inform, educate participants • Materials should be …

96. Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
    October 01, 2018 - ............................................................................................... 7 Participant … We also documented participant discussion and questions during the cyberseminar itself. … Participant Survey Results Of the nine participants surveyed, only three responded, despite receiving … Organizational Context Evaluation Results Evaluation of the Cyberseminar Evaluation of the EPC Report Participant

97. Technical-Brief-31-Mobile-Health-Applications-For-Self-Management-Of-Diabetes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
    May 01, 2018 - Outcomes: We included all patient-related outcomes, including but not limited to participant satisfaction … ; self-efficacy; participant assessments of usability of apps; costs; clinical outcomes such as HbA1c … The intervention group used the Dbees app and personal Web portal that allowed manual entry of participant … Participant mean age was 33.8 years. … The app also suggested medication changes, which were sent to both the participant and physician.

98. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - In addition, no participant developed rhabdomyolysis in any of the 27 8 RCTs investigating the five

99. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/ptsd-repository-update/protocol
    September 21, 2021 - ) Participants’ trauma type(s) Mean number of trauma types and traumatic events experienced per participant

100. Chronic Urinary Retention (CUR) Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-urinary-retention/research-protocol
     June 14, 2013 - control characteristics (intervention components, timing, frequency, duration); followup duration; participant … the risk-of-bias instrument for randomized controlled trials; the selected items likely will include participant